Výsledky vyhledávání

Akademický článek

Gastrodia elata Blume and its pure compounds protect BV-2 microglial-derived cell lines against β-amyloid: The involvement of GRP78 and CHOP

Autor: Lee Geum-Hwa, Kim Hyung-Ryong, Han Sang-Yong, Bhandary Bidur, Kim Do-Sung, Kim Min-Gul, So Byung-Ok, Kim Sun-Young, Jo Kyu-Sik, Lee Bo-Hee, Seo Hee-Nam, Chae Soo-Wan, Chae Han-Jung

Publikováno v: Biological Research, Vol 45, Iss 4, Pp 403-410 (2012)

Objectives: Gastrodia elata (GE) Blume (Orchidaceae) has been previously known for its therapeutic benefits against neurodegenerative diseases. Microglial activation and death have been implicated in the pathogenesis of a variety of neurodegenerative

Externí odkaz: https://doaj.org/article/c11e0dcfaaf04351abaccae227716ca0

Zobrazit plný text záznamu

Akademický článek

Improving intestinal health and mitigating Loperamide-Induced constipation through the modulation of Aquaporin-3 expression, reduction of oxidative stress, and suppression of inflammatory response by fermented rice extract

Autor: Lee, Hwa-Young, Kamal Hossain, Muhammad, Kim, Sun-Hu, Jeong, Pan-Young, Lee, Geum-Hwa, Kim, Do-Sung, Ja Chung, Myung, Chae, Han-Jung

Publikováno v: In Journal of Functional Foods October 2024 121

Zobrazit plný text záznamu

Akademický článek

Characterization of Salvia Miltiorrhiza ethanol extract as an anti-osteoporotic agent

Autor: Cui Yan, Bhandary Bidur, Marahatta Anu, Lee Geum-Hwa, Li Bo, Kim Do-Sung, Chae Soo-Wan, Kim Hyung-Ryong, Chae Han-Jung

Publikováno v: BMC Complementary and Alternative Medicine, Vol 11, Iss 1, p 120 (2011)

Abstract Background Salvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects. This study was conducted to examine the SM-indu

Externí odkaz: https://doaj.org/article/511be50028eb4292877508df022ee2fc

Zobrazit plný text záznamu

Akademický článek

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome

Autor: Kim Dal-Sik, Kim Young-Kon, Kim Do-Sung, Chae Han-Jung, Park Tae-Sun, Cho Young I, Jeong Seul-Ki

Publikováno v: Diabetology & Metabolic Syndrome, Vol 2, Iss 1, p 18 (2010)

Abstract Background Hepatic steatosis (HS), the most frequent liver disorder, was reported to be an independent predictor of cardiovascular disease. HS, if combined with the metabolic syndrome (MetS), might have a synergistic effect on low-density li

Externí odkaz: https://doaj.org/article/5021c1b91a9141faa23f9c86f5c4fc5f

Zobrazit plný text záznamu